Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 28,450 shares at $67.50 ($1.9M) on 2024-03-25, disclosed to the SEC on 2024-03-27.
Scheduled sale ($1.9M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.87 | 13,450 | $899K | 47.3% |
| 2 | $66.87 | 13,450 | $899K | 47.3% |
| 3 | $67.50 | 1,550 | $105K | 5.5% |
| Total | $66.90 avg | 28,450 | $1.9M | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |